BioMS Medical Corp (TSX: MS), a leading developer of products for the treatment of multiple sclerosis (MS), is pleased to announce the appointment of Mr. Bryan McKnight to the Company’s Board of Directors and Chair of the Audit Committee and Mr. Gordon Politeski as an advisor to the Board pending his nomination as a Director at the Company’s next annual meeting of shareholders.
